FGEN EV/EBITDA
-0.01
+0.02+66.67%
Wed, 22 Jan 2025 22:14:50 GMT
Summary:
As of January 23, 2025, FGEN EV/EBITDA is -0.01, with a rise of +0.02 (+66.67%) during the most recent trading day. Over the past year, it has increased by +0.47 (+97.92%). FGEN EV/EBITDA is now -100.02% below its all-time high of 61.74.FGEN EV/EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
FGEN EV/EBITDA Performance
PeriodPeriod | EV/EBITDAEV/EBITDA |
---|---|
todaytoday | +66.7% |
1 m1 month | -109.1% |
3 m3 months | -106.7% |
6 m6 months | +98.9% |
ytdytd | 0.0% |
1 y1 year | +97.9% |
5 y5 years | +100.0% |
FGEN EV/EBITDA High & Low
PeriodPeriod | HighHigh | Current vs highvs high | LowLow | Current vs lowvs low | |
---|---|---|---|---|---|
1 m | 1-month | 0.11 | -109.1% | -0.16 | +93.8% |
3 m | 3-month | 0.21 | -104.8% | -0.16 | +93.8% |
6 m | 6-month | 0.21 | -104.8% | -0.94 | +98.9% |
1 y | 1-year | 0.21 | -104.8% | -1.30 | +99.2% |
3 y | 3-year | 0.21 | -104.8% | -8.16 | +99.9% |
5 y | 5-year | 0.21 | -104.8% | -75.87 | +100.0% |
alltime | all time | 61.74 | -100.0% | -78.11 | +100.0% |
FibroGen EV/EBITDA History
Date | Value |
---|---|
2025 | -0.01(0.0%) |
2024 | -0.01(-98.0%) |
2023 | -0.49(-90.1%) |
2022 | -4.94(+9.3%) |
2021 | -4.52(-73.0%) |
2020 | -16.76(-76.2%) |
Date | Value |
---|---|
2019 | -70.43(+21.9%) |
2018 | -57.78(+81.5%) |
2017 | -31.83(+2.4%) |
2016 | -31.08(+16.8%) |
2015 | -26.62(-24.4%) |
2014 | -35.19 |
FAQ
- What is FibroGen EV/EBITDA?
- What is the all time high EV/EBITDA for FibroGen?
- What is FGEN EV/EBITDA year-to-date change?
- What is FibroGen EV/EBITDA year-on-year change?
What is FibroGen EV/EBITDA?
The current EV/EBITDA of FGEN is -0.01
What is the all time high EV/EBITDA for FibroGen?
FibroGen all-time high EV/EBITDA is 61.74
What is FGEN EV/EBITDA year-to-date change?
FibroGen EV/EBITDA has changed by 0.00 (0.00%) since the beginning of the year
What is FibroGen EV/EBITDA year-on-year change?
Over the past year, FGEN EV/EBITDA has changed by +0.47 (+97.92%)